Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 173 for “"Kinase Inhibition"”.

  1. Effects of Rho Kinase Inhibition on Cardioprotection

    Rho Kinase (Rho-K) has been implicated in the pathophysiology of many deleterious conditions and its inhibition was shown to ameliorate these compromising effects. It is unclear; however, whether inhibition of Rho-K would decrease infarct size in hearts after ischemia/reperfusion. Adult ICR mice …

    vcu Repository record for Effects of Rho Kinase Inhibition on Cardioprotection (opens in a new tab)

  2. EFFECTS OF ATM KINASE INHIBITION ON BRAIN DEVELOPMENT

    … ATM (Ataxia Telangiectasia Mutated), a protein kinase involved in DNA double strand breaks (DSB) repair, in orchestrating the maturation of GABAergic inhibition. Here we demonstrate that the exposure of wild-type neurons in a “critical window” during development to an inhibitor of ATM kinase …

    milano Repository record for EFFECTS OF ATM KINASE INHIBITION ON BRAIN DEVELOPMENT (opens in a new tab)

  3. The effects of tyrosine kinase inhibition on bone remodelling.

    Imatinib is a rationally-designed tyrosine kinase inhibitor that is a highly-successful treatment for chronic myeloid leukaemia (CML) and gastrointestinal stromal tumours. In a retrospective study, it was previously shown that imatinib therapy is associated with an increase in trabecular bone …

    adelaide Repository record for The effects of tyrosine kinase inhibition on bone remodelling. (opens in a new tab)

  4. RIP 1 kinase inhibition for acute ischemic kidney injury

    … Receptor interacting serine/threonine protein kinase 1 (RIPK1) is a crucial mediator of a form of regulated necrosis called necroptosis. PROJECT AIMS: -To determine if specific RIPK1 inhibition is beneficial in acute ischemic kidney injury. -To determine if there is evidence of necroptosis in …

    edinburgh Repository record for RIP 1 kinase inhibition for acute ischemic kidney injury (opens in a new tab)

  5. SPHINGOSINE KINASE INHIBITION AMELIORATES CHRONIC HYPOPERFUSION-INDUCED WHITE MATTER LESIONS

    WHITE MATTER LESIONS (WML) ARE THOUGHT TO CONTRIBUTE TO VASCULAR COGNITIVE IMPAIRMENT IN ELDERLY PATIENTS. GROWING EVIDENCE SHOW DISRUPTION OF OLIGODENDROCYTE PROGENITOR CELL (OPC) DIFFERENTIATION IS A CAUSE OF CHRONIC VASCULAR WHITE MATTER DAMAGE. IN THIS STUDY, WE INDICATED THAT BILATERAL CAROTID …

    nus Repository record for SPHINGOSINE KINASE INHIBITION AMELIORATES CHRONIC HYPOPERFUSION-INDUCED WHITE MATTER LESIONS (opens in a new tab) Download file for SPHINGOSINE KINASE INHIBITION AMELIORATES CHRONIC HYPOPERFUSION-INDUCED WHITE MATTER LESIONS (opens in a new tab)

  6. Development of lysine acylating small molecules for covalent kinase inhibition

    … benefited from the approval of novel covalent kinase inhibitors in the last decade. The most exemplified method for covalent kinase inactivation relies on Michael acceptors targeting non-conserved cysteine residues close to the active site. Despite its success in the clinic, this strategy is …

    strathclyde Repository record for Development of lysine acylating small molecules for covalent kinase inhibition (opens in a new tab)

  7. 6-phosphofructo-2-kinase inhibition induces autophagy as a survival mechanism.

    … to pyruvate, the family of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases (PFKFBs) control the conversion of fructose-6-phosphate to and from fructose-2,6-bisphosphate, a key regulator of the glycolytic enzyme phosphofructokinase-1 (PFK-1). One isoform, PFKFB3, has been shown to be …

    louisville Repository record for 6-phosphofructo-2-kinase inhibition induces autophagy as a survival mechanism. (opens in a new tab)

  8. Mutational analysis of isoform selectivity and conformational equilibria in protein kinase inhibition

    <p>Deregulation of protein kinases is associated with many diseases making them important targets for therapeutic intervention. Kinases can switch between active and inactive conformations that can be targeted by type 1 or type 2 inhibitors respectively. One of the most relevant conformational …

    oxford Repository record for Mutational analysis of isoform selectivity and conformational equilibria in protein kinase inhibition (opens in a new tab)

  9. Pim Kinase Inhibition: Single Agent and Combination Approaches In B-Cell Lymphoma

    … site for Moloney murine leukemia virus (Pim) kinases are Ser/Thr/Tyr kinases. They modulate B-cell development but become oncoproteins and promote cancer development once overexpressed. Containing three isoforms, Pim-1, -2 and -3 are known to phosphorylate various substrates that regulate …

    uthsc Repository record for Pim Kinase Inhibition: Single Agent and Combination Approaches In B-Cell Lymphoma (opens in a new tab)

  10. Investigating Pim kinase inhibition as a novel anti-thrombotic endothelium targeting strategy

    … associated with significant adverse effects. Pim kinases have emerged as novel regulators of platelet function and thrombosis and are expressed in endothelial cells. Their inhibition may therefore offer additional therapeutic benefit on thrombosis. This study investigates the effects of PIM1 …

    whiterose Download PDF for Investigating Pim kinase inhibition as a novel anti-thrombotic endothelium targeting strategy (opens in a new tab)

  11. Development of a Three-Hybrid Split-Luciferase System for Interrogating Protein Kinase Inhibition

    Eukaryotic protein kinases are one of the most important classes of human proteins, and a great deal of research has focused on the development of small molecule inhibitors as biological probes for the determination of their cellular function or as therapeutics for the treatment of disease, such as …

    arizona-thes Repository record for Development of a Three-Hybrid Split-Luciferase System for Interrogating Protein Kinase Inhibition (opens in a new tab)

  12. Development of Chemical Scaffolds for Kinase Inhibition Through Scaffold Hopping and Rational Design

    … as potent inhibitors of CLK1, DYRK1a and Pim-1 kinases. Chapter 1 details the motivations of this research, outlines the importance of kinase inhibitors in medicinal chemistry and introduces the CLK and DYRK kinases. Previous research towards the development of CLK1 and DYRK1a kinase inhibitors …

    unsw Repository record for Development of Chemical Scaffolds for Kinase Inhibition Through Scaffold Hopping and Rational Design (opens in a new tab)

  13. Preclinical Evaluation of Immunomodulatory Effects of Aurora Kinase Inhibition In Human Papillomavirus Positive Cancers

    … a large-scale drug screen and identified Aurora Kinase (AK) inhibitors as a unique class of reagents to induce selective apoptosis in HPV+, but not HPV- human tumor cells in vitro and in vivo in HPV+ patient derived xenografts (PDX) mouse models. We hypothesized that Aurora kinase inhibition …

    uthsc Repository record for Preclinical Evaluation of Immunomodulatory Effects of Aurora Kinase Inhibition In Human Papillomavirus Positive Cancers (opens in a new tab)

  14. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer

    … that decrease in pancreatic tumor growth due to inhibition of src activity is associated with the inability of src kinase to trigger a network of such signaling processes, which finally leads to endothelial cell death and dormancy of angiogenesis. The therapeutic efficacy of Src kinase inhibitor …

    lmu-germany Repository record for Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer (opens in a new tab)

  15. EGFR in Early Non-small Cell Lung Cancer: Tyrosine Kinase Inhibition in a Neoadjuvant Trial

    EGFR TKIs are standard therapy for advanced NSCLC. In order to define their role in early disease, we implemented a phase II trial of neoadjuvant gefitinib in clinical stage I NSCLC. Tumour shrinkage was seen in 43% of patients, with 11% achieving RECIST partial response (PR). Analysis of molecular …

    toronto-retro Repository record for EGFR in Early Non-small Cell Lung Cancer: Tyrosine Kinase Inhibition in a Neoadjuvant Trial (opens in a new tab)

  16. Gating Of A Non-Selective Cation Channel in Aplysia Neuroendocrine Cells by Tyrosine Kinase Inhibition

    … pipette saline and treated with the tyrosine kinases inhibitors, PP1 or SU6656, which evoked inward currents of 0.5-2 nA and 250-900 pA, respectively. These responses were associated with a statistically significant increase in membrane conductance, and a largely linear current that reversed …

    queens Repository record for Gating Of A Non-Selective Cation Channel in Aplysia Neuroendocrine Cells by Tyrosine Kinase Inhibition (opens in a new tab)

  17. Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells

    … levels of EGFR, nor inhibit downstream protein kinase B (PKB/Akt) activation. On the contrary, erlotinib treatment increased phosphorylated Akt in two of three cell lines. Levels of VEGF in conditioned media increased after erlotinib treatment as a single agent and in combination with radiation …

    guelph Repository record for Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells (opens in a new tab)

  18. Unconventional approaches to kinase inhibition : covalent inhibitors and docking site inhibitors of mitogen-activated protein kinases

    … and inter-pathway crosstalk makes complete inhibition of MAPKs necessary to stop signaling in a therapeutic context. Covalent, irreversible MAPK inhibitors can induce complete inhibition by being effectively immune to substrate competition, and by forcing recovery of signaling to be fully …

    texas Repository record for Unconventional approaches to kinase inhibition : covalent inhibitors and docking site inhibitors of mitogen-activated protein kinases (opens in a new tab)

Page 1 of 9